Ildong Pharmaceutical Co., Ltd.
Research Ildong Pharmaceutical Co., Ltd. (249420.KS) on Bullrun: market cap KRW 429.45B, dividend yield 1.6%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker249420.KS
- ExchangeKS
- CountrySouth Korea
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyKRW
- Market capKRW 429.45B
- Dividend yield1.6%
- Financial periodQ2 2026
- RevenueKRW 147.86B
- Net incomeKRW 5.70B
- Free cash flowKRW 8.26B
- Gross margin38.3%
Valuation Snapshot
latest market cap is KRW 429.45B; dividend yield is 1.6%.
Peer valuation comparison
Latest dividend yield is 1.55% versus a Healthcare sector median of 2.4% (35.4% below).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 429.45B | n/a | 1.5% | 200 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 200 KRW, yield 1.6%.
About Ildong Pharmaceutical Co., Ltd.
Ildong Pharmaceutical Co., Ltd. develops, manufactures, and sells pharmaceutical products in South Korea. The company offers active lactic acid bacterial and anti-diarrheal agents, antibiotics, antifungal and antiviral products, anti-cancer, antineoplastic agents, and NSAIDs and analgesics, as well as vitamins, minerals, and nutrients;
ETFs that hold Ildong Pharmaceutical Co., Ltd.
US-listed ETFs
Ildong Pharmaceutical Co., Ltd. is held by 16 US-listed ETFs, going by the latest portfolios they filed with the SEC. The 8 most traded of them:
| ETF | Weight | Fee |
|---|---|---|
| Vanguard FTSE Developed Markets Index Fund ETF Shares (VEA) | <0.01% | 0.03% |
| Vanguard Total International Stock Index Fund ETF Shares (VXUS) | <0.01% | 0.05% |
| Vanguard Total World Stock Index Fund ETF Shares (VT) | <0.01% | 0.06% |
| Avantis Emerging Markets Equity ETF (AVEM) | <0.01% | 0.33% |
| Vanguard FTSE Pacific Index Fund ETF Shares (VPL) | <0.01% | 0.07% |
| Vanguard FTSE All-World ex-US Small-Cap Index Fund ETF Shares (VSS) | 0.01% | 0.06% |
| Dimensional Emerging Core Equity Market ETF (DFAE) | <0.01% | 0.29% |
| Dimensional Emerging Markets Core Equity 2 ETF (DFEM) | <0.01% | 0.39% |
Portfolios as filed with the SEC on Form N-PORT, dated May to July 2026. Brokers in the EU generally do not offer US-listed ETFs to retail investors.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Ildong Pharmaceutical Co., Ltd.'s market cap?
Ildong Pharmaceutical Co., Ltd.'s market capitalization is KRW 429.45B.
Does Ildong Pharmaceutical Co., Ltd. pay a dividend?
Ildong Pharmaceutical Co., Ltd. has a dividend yield of 1.6%.
What does Ildong Pharmaceutical Co., Ltd. do?
Ildong Pharmaceutical Co., Ltd. develops, manufactures, and sells pharmaceutical products in South Korea. The company offers active lactic acid bacterial and anti-diarrheal agents, antibiotics, antifungal and antiviral products, anti-cancer, antineoplastic agents, and NSAIDs and analgesics, as well as vitamins, minerals, and nutrients; and drugs for blood circulation, cardiovascular and central nervous system, dental, endocrine and metabolic system, gastrointestinal system, respiratory system, and urogenital system applications.